Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
718 |
|
| Actual shortage: | 20 (3%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 604 (84%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
89 (9%) |
|
Overdue reports |
19 (73%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-PROPAFENONE | 150MG | TABLET | Avoided shortage | 2025-01-21 | 2025-03-04 | 248186 |
| MYLAN-PROPAFENONE | 150MG | TABLET | Resolved | 2025-03-04 | 2025-03-26 | 251913 |
| MYLAN-PROPAFENONE | 150MG | TABLET | Actual shortage | 2025-03-31 | 2025-05-05 | 253696 |
| MYLAN-PROPAFENONE | 300MG | TABLET | Anticipated shortage | 2025-04-23 | 2025-04-28 | 255422 |
| MYLAN-RABEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-05-04 | 2017-12-02 | 9016 |
| MYLAN-RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-05-05 | 2017-07-17 | 9188 |
| MYLAN-RILUZOLE | 50MG | TABLET | Resolved | 2017-10-26 | 2018-03-10 | 27146 |
| MYLAN-RILUZOLE | 50MG | TABLET | Resolved | 2021-03-24 | 2021-04-07 | 136159 |
| MYLAN-RILUZOLE | 50MG | TABLET | Avoided shortage | 2021-04-07 | 2021-04-28 | 136961 |
| MYLAN-RILUZOLE | 50MG | TABLET | Avoided shortage | 2021-08-18 | 2021-09-09 | 144291 |
| MYLAN-RILUZOLE | 50MG | TABLET | Resolved | 2021-10-13 | 2021-10-26 | 146987 |
| MYLAN-RILUZOLE | 50MG | TABLET | Resolved | 2025-01-07 | 2025-01-28 | 246898 |
| MYLAN-RILUZOLE | 50MG | TABLET | Avoided shortage | 2021-01-20 | 2021-02-09 | 132026 |
| MYLAN-RISEDRONATE | 35MG | TABLET | Resolved | 2017-04-04 | 2017-11-02 | 5310 |
| MYLAN-RISEDRONATE | 35MG | TABLET | Resolved | 2017-04-04 | 2017-11-02 | 5329 |
| MYLAN-RISEDRONATE | 150MG | TABLET | Resolved | 2017-05-05 | 2017-07-17 | 9368 |
| MYLAN-RISPERIDONE | 4.0MG | TABLET | Avoided shortage | 2017-03-17 | 2017-03-29 | 3368 |
| MYLAN-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-04-04 | 2017-09-08 | 5319 |
| MYLAN-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-04-04 | 2017-10-04 | 5338 |
| MYLAN-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-04-07 | 2018-02-15 | 5951 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VALSARTAN HCTZ | 25MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6845 |
| MYLAN-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20259 |
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51647 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-ZOPICLONE | 5MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48576 |
| MYLAN-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51665 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |